← back to search

Jean‐Paul Sculier

Institut Jules Bordet ·
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, and Neuroendocrine Tumor Research Advances.
h-index
58
citations
24,000
works
586
NIH funding
primary concept
email

Recent publications

Immune evasion before tumour invasion in early lung squamous carcinogenesis
Nature 2019cited by 334position: middledoi
The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer
Journal of Thoracic Oncology 2017cited by 505position: middledoi
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Journal of Thoracic Oncology 2016cited by 4,605position: middledoi
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer
Journal of Thoracic Oncology 2016cited by 724position: middledoi
The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
Journal of Thoracic Oncology 2016cited by 264position: middledoi
The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification
Journal of Thoracic Oncology 2016cited by 236position: middledoi
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma
Journal of Thoracic Oncology 2016cited by 212position: middledoi
The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification
Journal of Thoracic Oncology 2016cited by 198position: middledoi
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
Journal of Thoracic Oncology 2016cited by 177position: middledoi
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
Journal of Thoracic Oncology 2016cited by 176position: middledoi
The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
Journal of Thoracic Oncology 2016cited by 133position: middledoi
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation
Journal of Thoracic Oncology 2016cited by 82position: middledoi
ESR/ERS white paper on lung cancer screening
European Respiratory Journal 2015cited by 141position: lastdoi
ESR/ERS white paper on lung cancer screening
European Radiology 2015cited by 140position: lastdoi
The European initiative for quality management in lung cancer care
European Respiratory Journal 2014cited by 50position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2015–2015)Oyunbileg von Stackelberg · DKFZ-ZMBH Alliance2 papers (2015–2015)Hans‐Ulrich Kauczor · German Cancer Research Center2 papers (2015–2015)Martine Rémy‐Jardin · Albert Einstein College of Medicine2 papers (2015–2015)Nir Peled · University Medical Center2 papers (2015–2015)Mina Gaga · Isabela State University2 papers (2015–2015)Kristiaan Nackaerts · Radboud University Medical Center2 papers (2015–2015)Mathias Prokop · Radboud University Nijmegen2 papers (2015–2015) · 1 papers (2019–2019)Vincent Ninane · KU Leuven1 papers (2019–2019)Bénédicte Buttard · Laboratoire d’immunologie intégrative du cancer1 papers (2019–2019)Céline Mascaux · Hôpital Civil, Strasbourg1 papers (2019–2019)Annick Haller · University of California System1 papers (2019–2019) · 1 papers (2019–2019) · 1 papers (2019–2019)Karen Willard‐Gallo · Institut Jules Bordet1 papers (2019–2019) · 1 papers (2019–2019)Jennifer Beane · Boston University1 papers (2019–2019)Avi Spira · University of Vermont Medical Center1 papers (2019–2019)Jérôme Galon · Inserm1 papers (2019–2019)